Reference
Institute for Clinical and Economic Review. ICER to Assess Whether the Most Significant Prescription Drug Price Increases Are Supported by New Clinical Evidence. Internet Document : 19 Jun 2020. Available from: URL: https://icer-review.org/announcements/icer-to-assess-whether-the-most-significant-prescription-drug-price-increases-are-supported-by-new-clinical-evidence-2/
Rights and permissions
About this article
Cite this article
ICER review on unsupported drug price increases in USA. PharmacoEcon Outcomes News 856, 3 (2020). https://doi.org/10.1007/s40274-020-6903-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-6903-5